Greenanew was founded in 2019, which is a technology-driven provider of products and services for big health, providing green and low-carbon solutions for big health industry.
Greenanew Biotech is driven by synthetic biology and chemical synthesis, and takes synthetic biology, electrochemistry and continuous flow chemistry as the core technology path to create a green intelligent manufacturing technology platform.
The company's business involves functional nutrition raw materials and formulation products, new liposome excipients, anti-tumor and halothane inhalation anesthetics, on this basis, it will expand to other bio-based products, fluorine-containing characteristic APIs, green new materials. The company's goals of technological innovation are: unmet product demand in the market, green, low-carbon and safe production technology pain points to be solved in production.